Site is Being Upgraded

Lengthening the lifespan of mighty humans with a tiny probiotic Bifidobacterium lactis (BL) HY8101: Probiotic Bifidobacterium lactis (BL) HY8101 may  increase insulin sensitivity, slow down cardiac aging, and increase lifespan, via up-regulation of BubR1 and others longevity-promoting genes, 7/November/2018, 11.26 pm

Cancer therapy targeting cancer stem cells in chronic myelogenous leukemia (CML) and other metastatic cancers: Misoprostol, an FDA-approved EP4 agonist and abortion-promoting drug, increases the expression of tumor suppressor genes, such as IGFBP3, PIAS3, p53, and TA-p73/p63, targets CML leukemic stem cells, confers protection against CML and prolongs survival, via up-regulation of its target gene, 6/November/2018,11.28 pm
November 6, 2018
A probiotic way to stay free of blood sugar disease (autoimmune diabetes): Probiotic Clostridium Butyricum increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 7/november/2018, 11.40 pm
November 7, 2018
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston, USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Lengthening the lifespan of mighty humans with a tiny probiotic Bifidobacterium lactis (BL) HY8101: Probiotic Bifidobacterium lactis (BL) HY8101 may  increase insulin sensitivity, slow down cardiac aging, and increase lifespan, via up-regulation of BubR1 and others longevity-promoting genes

 


From research findings to Therapeutic Opportunity: 

This study suggests, for the first time, that probiotic Bifidobacterium lactis (BL) HY8101by increasing the expression of their target gene, it may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (fig. 1).

Figure 1. Probiotic Bifidobacterium lactis (BL) HY8101 may extend  mammalian lifespan via up-regulation of BuBR1 and down-regulation of p70 S6 Kinase

Figure 2. Probiotic Bifidobacterium lactis HY8101 function as a longevity-promoting agent.

 

 

 

 

 

 

 

 

 

Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median lifespan. Thus, probiotic Bifidobacterium lactis (BL) HY8101, either alone or in combination with other drugs, may be used to extend the lifespan of an individual (fig.2).

[easy_payment currency=”USD”]


Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $750#

Undisclosed mechanistic information: How does probiotic  Bifidobacterium lactis (BL) HY8101 increase the expression of BubR1?

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com

 

 

CitationBoominathan, L., Lengthening the lifespan of mighty humans with a tiny probiotic Bifidobacterium lactis (BL) HY8101: Probiotic Bifidobacterium lactis (BL) HY8101 may  increase insulin sensitivity, slow down cardiac aging, and increase lifespan, via up-regulation of BubR1 and others longevity-promoting genes, 7/November/2018, 11.24 pm,  Genome-2-BioMedicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Comments are closed.